Cellular Health Screening Market size was valued at USD 3.24 billion in 2024 and is set to exceed USD 10.05 billion by the end of 2037, registering over 9.1% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of cellular health screening is estimated at USD 3.48 billion.. The growth of this market can be primarily driven by the increasing prevalence of cancer all over the world. In 2022, in the United States around 1.9 cancer cases were reported and 609,360 people lost their lives due to cancer. In order to offer proper treatment on time cell analyzing aids in the detection of malignancies before they spread in the whole body. The detection of malignancies before the visibility of symptoms is possible with the aid of cell health screening.
The rising use of cellular health screening in customized medicine and the government's increased emphasis on preventative care are both responsible for the market's expansion. For market participants in this industry, the potential uses of cellular health screening in customized medicine have created tremendous growth potential. In prostate cancer and breast cancer cells grown in the lab, researchers were able to inhibit telomerase activity, leading to tumor growth.
Growth Drivers
Challenges
Base Year |
2024 |
Forecast Year |
2025-2037 |
CAGR |
9.1% |
Base Year Market Size (2024) |
USD 3.24 billion |
Forecast Year Market Size (2037) |
USD 10.05 billion |
Regional Scope |
|
Sample (Blood, Saliva, Serum, Urine)
Cellular health screening market from the blood sample segment is slated to hold 40% of the revenue share by 2037. The factors contributing to this segment's growth are a high incidence of blood sample use by physicians, as well as the application of diagnostic kits for the assessment of different disease conditions, organ function, and risk factor analysis. Also, market growth is being stimulated by the launch of new diagnostic devices that use blood to detect and screen. In the case of Osler, for example, a blood test company that's raising funding before it gets ready to launch its diagnostics device. The new technology will give you a result in less than 10 minutes and it wants to provide cheap blood tests.
Collection Site (Home, Office, Hospital, Diagnostic Labs)
The home segment in the cellular health screening market is poised to grow substantially during the forecast period. This is explained by rising health consciousness and widespread use of self-sampling in important marketplaces. Self-sampling has become popular because it is simple to use and doesn't call for specialized equipment or qualified personnel. Additionally, the COVID-19 epidemic resulted in a widespread choice for home collections because of the restrictions on movement, and this choice will persist for years to come. For instance, Lab Corp declared in April 2022 that it had begun offering home collection services for the company's range of diagnostic and examination offers.
Our in-depth analysis of the global market includes the following segments:
Type |
|
Sample |
|
Collection Site |
|
North American Market Forecasts
The North America region is set to hold 33% share of the global cellular health screening market by 2037. The growth of this market can be attributed on the back of increasing awareness about personalized medicines, growing government initiatives supporting preventive healthcare, and growing adoption of new technologies. Besides this robust expansion of healthcare infrastructure in the North America region is estimated to boost the market growth of cellular health screening in this region during the projection period. In June 2021, Grail launched a unique blood test capable of detecting the presence of multiple cancers using the Galleri diagnostic method. This test is intended to screen people at high risk of cancer, such as adults over 50 years old. Such initiatives by major players in the market are leading to increased adoption of cellular health screening in the region, thereby driving market growth.
Asia Pacific Market Statistics
The cellular health screening market in the Asia Pacific is estimated to hold a substantial growth during the forecast timeframe. The increase in the number of people, which is contributing to a large patient pool and creating an infrastructure for health care due to increased economic activity, accounts for this. The key drivers for growth in the Asia Pacific region include improved adoption of tests and awareness by adults about their health. Regional growth is also supported by higher research on telomere senescence, as well as public policies aimed at preventing diseases.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?